HTGC NYSE
Hercules Capital, Inc.
1W: +1.8%
1M: -1.9%
3M: +6.8%
YTD: -9.2%
1Y: -3.4%
3Y: +33.5%
5Y: +53.1%
$16.58
+0.17 (+1.04%)
Weekly Expected Move ±2.4%
$16
$16
$16
$17
$17
Credit Risk of going bust: not rated, financial company (lending is its business) Bonds: none of note held by US funds details ▾
Not rated: lending and leverage are a financial company's business, which the model misreads.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
2 relationships0
As Filer
counterparties named
2
As Counterparty
mentioned by others
2022-11-01
Earliest Filing
2023-07-24
Latest Filing
Mentioned As Counterparty
2 mentionsOther companies that named HTGC in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| HRTX HERON THERAPEUTICS, INC. /DE/ | investor | Purchaser of common stock and pre-funded warrants in a private placement. | 2023-07-24 | View |
| PHAT Phathom Pharmaceuticals, Inc. | investor | Initial Investor and Administrative/Collateral Agent in Revenue Interest Financing Agreement | 2022-11-01 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-08 | Material Agreement; Financial Obligation; Other Events; Exhibits | Agreement | View |
| 2026-09-17 | Officer/Director Change; Other Events; Exhibits | View | |
| 2026-07-30 | Earnings Release; Other Events; Exhibits | View | |
| 2026-07-24 | Material Agreement; Financial Obligation; Other Events; Exhibits | Agreement | View |
| 2026-07-21 | Earnings Release; Other Events | View | |
| 2026-06-18 | Shareholder Vote; Exhibits | View | |
| 2026-05-05 | Earnings Release; Other Events; Exhibits | View | |
| 2026-05-04 | Officer/Director Change; Exhibits | View | |
| 2026-02-12 | Results of Operations and Financial Condition; Other Events; Financial Statements and Exhibits | View | |
| 2026-02-10 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Other Events; Fin | Agreement | View |
| 2026-02-03 | Results of Operations and Financial Condition; Other Events | View | |
| 2025-10-30 | Results of Operations and Financial Condition; Other Events; Financial Statements and Exhibits | View | |
| 2025-07-31 | Results of Operations and Financial Condition; Other Events; Financial Statements and Exhibits | View | |
| 2025-06-20 | Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View | |
| 2025-06-16 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Other Events; Fin | Agreement | View |
| 2025-05-01 | Results of Operations and Financial Condition; Other Events; Financial Statements and Exhibits | View | |
| 2025-03-10 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2025-03-06 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-03-05 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-02-13 | Results of Operations and Financial Condition; Other Events; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR